In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
Trace Adkins is hitting the road in 2026 to celebrate three decades of music. The country singer will embark on his 30th Anniversary Tour, and fans won't have to wait long to see him. The trek ...
DNA Ginkgo Bioworks Holdings, Inc.
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...
The National Football League is one of the biggest football leagues in the world. It has become a breeding ground for star athletes. Players within the league have an equal shot at success due to a ...
If you encounter any difficulties in using or reproducing the code, please contact me at [email protected]. ReCode introduces recursive code generation for LLM agents, unifying plan and action ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results